138 results
8-K
EX-10.4
DYAI
Dyadic International Inc., DE
11 Mar 24
Dyadic Announces Closing of Private Placement of
8:45am
8-K
EX-10.2
DYAI
Dyadic International Inc., DE
11 Mar 24
Dyadic Announces Closing of Private Placement of
8:45am
8-K
EX-10.3
DYAI
Dyadic International Inc., DE
11 Mar 24
Dyadic Announces Closing of Private Placement of
8:45am
8-K
EX-10.1
otl0xoyukpq
11 Mar 24
Dyadic Announces Closing of Private Placement of
8:45am
8-K
EX-10.1
vwqgua
19 Sep 23
Dyadic Announces Development and License Agreement to Commercialize Animal-Free Alternative Proteins Using DapibusTM
8:30am
8-K
EX-10.1
mqp6 ll5h5
12 Apr 23
Dyadic Announces Expanded Licensing Agreement to Develop and Commercialize Vaccines and Biologics for African Continent
8:30am
8-K
EX-10.1
80uu ezlcrw3fro
23 Jan 23
Dyadic Announces Sale of Equity Interest in Alphazyme
5:22pm
8-K
EX-10.1
epf7 nfa7s
11 May 22
Dyadic Announces Research, License and Collaboration for the Manufacture of
9:57am
8-K
EX-10.1
0r4yjbbu jol5xoghqo
17 Dec 21
Dyadic Announces Research, License and Collaboration Agreement with Janssen
7:10am
8-K
EX-10.1
cb0r6
9 Nov 21
Dyadic Appoints Chief Business Officer to Executive Leadership Team
8:40am
8-K
EX-10.1
31c6bs6c41us
11 Aug 21
Entry into a Material Definitive Agreement
8:32am
8-K
EX-10.3
buy5hsr511knljs2m
27 Jul 21
Entry into a Material Definitive Agreement
8:33am
8-K
EX-10.1
oiym7bvcz5k4ii
27 Jul 21
Entry into a Material Definitive Agreement
8:33am
8-K
EX-10.2
qan 1i7rjstwrr
27 Jul 21
Entry into a Material Definitive Agreement
8:33am